Last reviewed · How we verify

NCT03656770

Measuring Beliefs and Norms About Persons With Mental Illness

Completed NA Last updated 12 August 2019
What this trial tests

NA trial testing Survey questionnaire in Mental Illness in 1,782 participants. Completed in 8 June 2018.

Timeline
13 December 2016
Primary endpoint
8 June 2018
8 June 2018

Quick facts

Lead sponsorMassachusetts General Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposeother
Enrollment1,782
Start date13 December 2016
Primary completion8 June 2018
Estimated completion8 June 2018
Sites1 location across Uganda

Drugs / interventions tested

Conditions studied

Sponsor

Massachusetts General Hospital

Who can join

18 and older, any sex, with Mental Illness or Schizophrenia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Survey experiment to estimate drivers of mental illness stigma

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Portrayals of mental illness, treatment, and relapse and their effects on the stigma of mental illness: Population-based, randomized survey experiment in rural Uganda.
    Rasmussen JD, Kakuhikire B, Baguma C, Ashaba S, et al · · 2019 · cited 22× · PMID 31539373 · DOI 10.1371/journal.pmed.1002908

Verify or expand the search:

Other trials of Survey questionnaire

Trials testing the same drug.

Other recruiting trials for Mental Illness

Currently open trials in the same condition.

Other Massachusetts General Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03656770.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing